Organigram Global (OGI) Current Assets (2018 - 2025)
Organigram Global (OGI) posted quarterly Current Assets of $207.0 million for Q3 2025, up 7.7% year-on-year from $192.2 million in Q3 2024, and up 7.7% on a QoQ basis from $192.2 million in Q3 2024.
Organigram Global (OGI) Current Assets (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Current Assets for 8 consecutive years, with $207.0 million the latest figure, recorded in Q3 2025.
- Quarterly Current Assets rose 7.7% year-over-year to $207.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $207.0 million (up 7.7% YoY) and the FY2025 annual result came in at $207.0 million, up 7.7% from the prior year.
- Current Assets advanced to $207.0 million in Q3 2025 per OGI's latest filing, from $192.2 million in the prior quarter.
- Over the last five years, Current Assets for OGI reached as high as $209.7 million in Q3 2021 and fell as low as $116.3 million in Q3 2023.
- A 5-year average of $171.6 million and a median of $182.2 million in 2022 frame the typical range for Current Assets.
- The largest YoY upside for Current Assets was 65.52% in 2021 against a maximum downside of 36.52% in 2021.
- Year by year, Current Assets stood at $209.7 million in 2021, then declined by 17.92% to $172.1 million in 2022, then plunged by 32.39% to $116.3 million in 2023, then surged by 65.21% to $192.2 million in 2024, then gained by 7.7% to $207.0 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $207.0 million, $192.2 million, and $116.3 million for Q3 2025, Q3 2024, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 207.02 Mn |
| Sep 30, 2024 | 192.22 Mn |
| Sep 30, 2023 | 116.35 Mn |
| Aug 31, 2022 | 172.09 Mn |
| Aug 31, 2021 | 209.66 Mn |
| Feb 28, 2021 | 132.25 Mn |
| Nov 30, 2020 | 208.38 Mn |
| Aug 31, 2020 | 126.66 Mn |
| May 31, 2020 | 116.30 Mn |
| Feb 29, 2020 | 208.33 Mn |
| Aug 31, 2019 | 148.47 Mn |
| May 31, 2019 | 232.47 Mn |
| Aug 31, 2018 | 155.21 Mn |